Skip to main content
InterCure Ltd. (INCR)
NASDAQ: INCR · IEX Real-Time Price · USD
2.300
+0.020 (0.88%)
At close: Jul 19, 2024, 4:00 PM
2.390
+0.090 (3.91%)
Pre-market: Jul 22, 2024, 7:20 AM EDT

InterCure Revenue

In the year 2023, InterCure had annual revenue of $97.95M.

Revenue (ttm)
$97.95M
Revenue Growth
-3.88%
P/S Ratio
1.07
Revenue / Employee
$362,772
Employees
270
Market Cap
104.82M USD

Revenue Chart

* The company reports in ILS currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202397.95M-11.85M-10.79%
Dec 31, 2022109.80M41.15M59.94%
Dec 31, 202168.65M48.33M237.78%
Dec 31, 202020.32M17.77M696.91%
Dec 31, 20192.55M--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
FibroGen 167.49M
CytomX Therapeutics 119.18M
BrainsWay 34.26M
Oramed Pharmaceuticals 674.00K
Zentek 21.92K
Revenue Rankings

INCR News

More News